Notice Number: NOT-NS-16-028
Key Dates
Release Date: May 24, 2016
PAR-13-278
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The purpose of this Notice to inform interested applicants that the expiration date for PAR-13-278 "NINDS Phase III Investigator-Initiated Efficacy Clinical Trials (U01)" will be extended by one funding cycle.
The Key Dates table is updated accordingly:
Part 1. Key Dates
Posted Date |
July 22, 2013 |
Open Date (Earliest Submission Date) |
September 5, 2013 |
Letter of Intent Due Date(s) |
Not Applicable |
Application Due Date(s) |
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review |
Standard dates apply |
Advisory Council Review |
Standard dates apply |
Earliest Start Date |
Standard dates apply |
Expiration Date |
January 8, 2017 |
Due Dates for E.O. 12372 |
Not Applicable |
Inquiries
Please direct all inquiries to:
Peter Gilbert
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-0870
Email: [email protected]
and Human Services (HHS)
